GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » Sale Of Property, Plant, Equipment

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Sale Of Property, Plant, Equipment : ¥0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co Sale Of Property, Plant, Equipment?

Wuhan Hiteck Biological Pharma Co's sale of property, plant, equipment for the three months ended in Sep. 2024 was ¥0.0 Mil. It means Wuhan Hiteck Biological Pharma Co gained ¥0.0 Mil from selling property, plant, and equipment. Wuhan Hiteck Biological Pharma Co's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.0 Mil.

Compared with last quarter (¥0.0 Mil in Jun. 2024 ), Wuhan Hiteck Biological Pharma Co gained the same money from selling property, plant, and equipment in Sep. 2024 (¥0.0 Mil).


Wuhan Hiteck Biological Pharma Co Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co Sale Of Property, Plant, Equipment Chart

Wuhan Hiteck Biological Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.04 0.02 0.02 2.07

Wuhan Hiteck Biological Pharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.81 - - - -

Wuhan Hiteck Biological Pharma Co Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Hiteck Biological Pharma Co Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Wuhan Hiteck Biological Pharma Co's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Hiteck Biological Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Executives
Yan Jie Director
Li Sheng Qiang Executives

Wuhan Hiteck Biological Pharma Co Headlines

No Headlines